USPTO serial 79268712
BENEVOLENT PLATFORM
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Sep 28, 2021
- Examiner
- AVENT, TEAGUE A
- Law office
- TMO LAW OFFICE 126
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with BENEVOLENT PLATFORM?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,795*
Plus Government fees of $1,625
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Leigh Ann Lindquist
Leigh Ann Lindquist Sughrue Mion PLLC2000 Pennsylvania Ave., NW Suite 9000Washington, DC 20006UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Computer software for accessing, browsing and searching online databases; computer software for creating searchable databases of information and data; computer software for data analysis, pattern discovery, contextual prediction, predictive analytics and predictive modelling; computer hardware and computer operating software in relating to artificial intelligence apparatus; artificial intelligence software for searching, tracking, exploration and analysis of data for use in the field of healthcare; artificial intelligence software for searching, tracking, exploration and analysis of data for use in the research and development of pharmaceutical preparations and medicines; artificial intelligence software for data analysis, pattern discovery, contextual prediction, predictive analytics and predictive modelling; recorded electronic computer databases in the fields of healthcare and pharmaceutical research and development; recorded electronic databases in the fields of healthcare and pharmaceutical research and development; recorded interactive electronic databases in the fields of healthcare and pharmaceutical research and development; data processing software | ACTIVE | — |
| 035 | Advertising, marketing and promotional services; database management; computer database management; compilation and systemization of information and data in computer databases; compilation of statistical information and data relating to medical research for business purposes; compilation of statistical information and data relating to scientific research for business purposes; compilation of information and data for use in the research and development of pharmaceutical preparations and medicines for business purposes; data processing; online data processing services; online data processing services for the pharmaceutical and healthcare industries; providing business information for use in predictive analytics and predictive modelling via computer databases; providing business statistical information for use in predictive analytics and predictive modelling via computer databases | ACTIVE | — |
| 041 | Educational services, namely, conducting informal on-line programs in the fields of healthcare and pharmaceutical research and development; on-line academic library services provided by means of a computerised database; on-line academic library services related to data stored and retrieved by electronic means; publication of books; publication of journals; publication of electronic books and journals online; publication of material which can be accessed from databases or from the Internet, namely, publication of periodicals; publication of the results of clinical trials, namely, publication of periodicals; publication of the results of clinical trials for pharmaceutical preparations, namely, publication of periodicals | ACTIVE | — |
| 042 | Design and development of computer software; providing online non-downloadable computer software for searching, tracking, exploration and analysis of data for use in the field of healthcare; providing online non-downloadable computer software for searching, tracking, exploration and analysis of data for use in the research and development of pharmaceutical preparations and medicines; providing online non-downloadable computer software for data analysis, pattern discovery, contextual prediction, predictive analytics and predictive modelling; providing online non-downloadable computer software for data analysis, pattern discovery, contextual prediction, predictive analytics and predictive modelling in the field of healthcare; providing online non-downloadable computer software for data analysis, pattern discovery, contextual prediction, predictive analytics and predictive modelling for use in the research and development of pharmaceutical preparations and medicines; Platform as a Service (PaaS), namely, providing artificial intelligence software platforms for searching, tracking, exploration and analysis of data for use in the field of healthcare; Platform as a Service (PaaS), namely, providing artificial intelligence software platforms for searching, tracking, exploration and analysis of data for use in the research and development of pharmaceutical preparations and medicines; Platform as a Service (PaaS) services, namely, providing an application platform interface for use by others for the collection, aggregation, compilation, dissemination, transmission, and processing of data for use in predictive modelling and predictive analytics; Platform as a Service (PaaS) services, namely, providing an application platform interface for use by others for the collection, aggregation, compilation, dissemination, transmission, and processing of data for use in predictive modelling and predictive analytics in the field of healthcare; Platform as a Service (PaaS) services, namely, providing an application platform interface for use by others for the collection, aggregation, compilation, dissemination, transmission, and processing of data for use in predictive modelling and predictive analytics in the research and development of pharmaceutical preparations and medicines; Software as a Service (SaaS), namely, providing artificial intelligence software for searching, tracking, exploration and analysis of data for use in the field of healthcare; Software as a Service (SaaS), namely, providing artificial intelligence software for searching, tracking, exploration and analysis of data for use in the research and development of pharmaceutical preparations and medicines; Software as a Service (SaaS), namely, providing artificial intelligence software for data analysis, pattern discovery, contextual prediction, predictive analytics and predictive modelling; Software as a Service (SaaS), namely, providing artificial intelligence software for data analysis, pattern discovery, contextual prediction, predictive analytics and predictive modelling in the field of healthcare; Software as a Service (SaaS), namely, providing artificial intelligence software for data analysis, pattern discovery, contextual prediction, predictive analytics and predictive modelling for use in the research and development of pharmaceutical preparations and medicines; consulting services in the field of cloud computing; hosting platforms being websites on the Internet; hosting of digital content online; hosting of digital content, namely, online journals; computer programming; writing of computer programs for medical applications; writing of computer programs for biotechnological applications; writing of data processing programs; scientific and medical research and development services; scientific research conducted using databases and the Internet; medical research services; pharmaceutical research and development services; pharmaceutical product evaluation; research and development of pharmaceutical preparations and medicines; research and development of pharmaceuticals for the treatment of age-related diseases and cancer; drug discovery services; services for assessing the efficiency of veterinary drugs in the nature of veterinary laboratory services; services for assessing the efficiency of pharmaceuticals in the nature of medical laboratory services; conducting early evaluations in the field of new pharmaceuticals in the nature of conducting clinical trials for others; consulting services in the fields of pharmaceutical research and development; information technology consulting services for the pharmaceutical and healthcare industries; providing scientific information about the results of clinical trials for pharmaceutical products; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing information, advisory and consultancy services regarding information technology services for the pharmaceutical and healthcare industries, all of the aforesaid services also provided online via a database or the Internet; providing information, advisory and consultancy services regarding research and development of pharmaceutical preparations and medicines, all of the aforesaid services also provided online via a database or the Internet; providing information and data relating to veterinary research and development, all of the aforesaid services also provided online via a database or the Internet; providing information concerning research and development of pharmaceuticals, all of the aforesaid services also provided online via a database or the Internet | ACTIVE | — |
| 044 | Healthcare services; healthcare information, advisory and consultancy services; medical services; medical information, advisory and consultancy services; medical testing for diagnostic or treatment purposes; pharmaceutical services being pharmaceutical advice; pharmaceutical information, advisory and consultancy services; veterinary services; veterinary information, advisory and consultancy services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by BenevolentAI Limited
- Other trademarks owned by BenevolentAI Limited
- Other trademarks owned by BenevolentAI Limited
- Other trademarks in Class 009
- Other trademarks in Class 035
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named BENEVOLENT PLATFORM
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 28, 2026 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Jul 15, 2022 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jul 15, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 15, 2022 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Jul 15, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 15, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 15, 2022 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Apr 4, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 16, 2022 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Mar 16, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 16, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 16, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 16, 2022 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Mar 14, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Mar 14, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Dec 28, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Sep 28, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 18, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jul 13, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 13, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 23, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jun 23, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jun 23, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 3, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 1, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 1, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 1, 2021 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Mar 21, 2021 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Mar 3, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 3, 2021 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Feb 25, 2021 | GNS1 | NOTIFICATION OF SUBSEQUENT FINAL EMAILED | — |
| Feb 25, 2021 | GNSF | SUBSEQUENT FINAL EMAILED | — |
| Feb 25, 2021 | CFRC | SUBSEQUENT FINAL REFUSAL WRITTEN | — |
| Jan 26, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 25, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 25, 2021 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jul 30, 2020 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jul 23, 2020 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jul 23, 2020 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 23, 2020 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 15, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 14, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 14, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 1, 2019 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 14, 2019 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 14, 2019 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 24, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 23, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 10, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 6, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 6, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 3, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |